These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 5319220)

  • 1. [The influence of the simultaneous administration of 5-bromosalicylohydroxamic acid (T-40) and isonicotinic acid hydrazide on the concentration of free isonicotinic acid hydrazide in the urine of patients with pulmonary tuberculosis].
    Zduńczyk-Pawelek H; Otrzonsek N; Kostrzewska K
    Gruzlica; 1965 May; 33(5):411-5. PubMed ID: 5319220
    [No Abstract]   [Full Text] [Related]  

  • 2. Importance of acetylation and oxidation in inactivation of isonicotinic acid hydrazide preparations.
    Smirnov GA
    Fed Proc Transl Suppl; 1966; 25(1):72-6. PubMed ID: 5322111
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of simultaneous administration of 5-bromosalicylhydroxamic acid (T40) and INH on the concentration of free INH in urine of tubercular patients].
    Zduńczyk-Pawelek H; Otrzonsek N; Kostrzewska K
    Z Tuberk Erkr Thoraxorg; 1965; 124(3):149-52. PubMed ID: 5899137
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical results obtained with Isoprodian in the treatment of new cases of pulmonary tuberculosis.
    Sighart H
    Scand J Respir Dis Suppl; 1978; 102():60-1. PubMed ID: 356259
    [No Abstract]   [Full Text] [Related]  

  • 5. [Levels of isonicotinic acid amide in patients with pulmonary tuberculosis treated with isonicotinic acid hydrazide and ethionamide].
    Sosnowski W; Rozniecki J; Podoska M; Galamon T
    Gruzlica; 1970 Oct; 38(11):1089-95. PubMed ID: 4249764
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of pulmonary tuberculosis by the one-time administration of preparations depending on the degree of isonicotinic acid hydrazide inactivation].
    Oliferovskaia RP
    Sov Med; 1972 Apr; 35(4):104-7. PubMed ID: 4662426
    [No Abstract]   [Full Text] [Related]  

  • 7. Polymeric complexes of isonicotinic acid hydrazide with antituberculosis effects.
    Slivkin AI; Lapenko VL; Bychuk AI; Suslina SN; Slivkin DA; Kornienko SV; Belenova AS
    Bull Exp Biol Med; 2013 Oct; 155(6):764-6. PubMed ID: 24288761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy of tuberculosis for the 1980's.
    Dutt AK; Stead WW
    Prim Care; 1980 Sep; 7(3):513-27. PubMed ID: 7003628
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ethambutol in association with isonicotinic acid hydrazide in the therapy of pulmonary tuberculosis primary infection. (Case reports and comparison with the association of streptomycin and isoniazid)].
    Briccarello L; Ferraro U; Vercellino E
    G Ital Mal Torace; 1968; 22(2):81-9. PubMed ID: 5704055
    [No Abstract]   [Full Text] [Related]  

  • 10. Tolerability and efficacy of isoprodian-containing antituberculosis regimens.
    Kleeberg HH
    S Afr Med J; 1986 Feb; 69(3):161. PubMed ID: 3511545
    [No Abstract]   [Full Text] [Related]  

  • 11. [Content of pyridoxine (vitamin B6) in the body of patients with pulmonary tuberculosis treated with isonicotinic acid hydrazide and ethionamide evaluated by means of the tryptophan test].
    Sosnowski W; Rózniecki J; Lowkis L; Galamon T
    Postepy Hig Med Dosw; 1968; 22(3):483-8. PubMed ID: 5669146
    [No Abstract]   [Full Text] [Related]  

  • 12. [The use of the triple association of isoniazid, isonicotinic thioamides and ethambutol in antitubercular therapy. (preliminary note)].
    Daddi G; Grassi C
    G Ital Mal Torace; 1966; 20(4):181-4. PubMed ID: 5981894
    [No Abstract]   [Full Text] [Related]  

  • 13. [Changes in ECG following intravenous administration of isonicotinic acid hydrazide].
    Dettlaff Z
    Gruzlica; 1969 Aug; 37(8):767-71. PubMed ID: 5352303
    [No Abstract]   [Full Text] [Related]  

  • 14. [Modified method for indicating antitubercular agents in the urine in tuberculosis].
    Solov'eva AS; Lukomskaia VM
    Lab Delo; 1980; (12):756-7. PubMed ID: 6163900
    [No Abstract]   [Full Text] [Related]  

  • 15. [Features of isoniazid activation in patients with tuberculosis and diabetes mellitus].
    Karachunskiĭ MA; Kaminskaia GO; Kossiĭ IuE; Chernykh NA
    Probl Tuberk; 2001; (7):26-7. PubMed ID: 11763557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Medullary aplasia after administration of isonicotinic acid hydrazide (INH)].
    Baran E; Berneagă O; Vacariu O; Tomoşoiu G
    Rev Med Chir Soc Med Nat Iasi; 1973; 77(3):607-12. PubMed ID: 4742729
    [No Abstract]   [Full Text] [Related]  

  • 17. [Results of initial treatment of pulmonary tuberculosis using ethambutol, isonicotinic acid hydrazide and rifampicin].
    Kesztele V; Niederkofler J
    Wien Med Wochenschr; 1970 Jun; 120(25):473-5. PubMed ID: 5518004
    [No Abstract]   [Full Text] [Related]  

  • 18. [The clinical and pharmacokinetic features of lymphotropic therapy in patients with new-onset pulmonary tuberculosis].
    Priakhina VN; Kolpakov MA; Kolpakov AR; Zyrianova TV; Mokhina OG
    Probl Tuberk Bolezn Legk; 2005; (6):55-8. PubMed ID: 16078725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Active fraction of isonicotinic acid hydrazide in the blood of tuberculosis patients during its combined use with PAS].
    Dudchik GKh; Bilyk MA
    Vrach Delo; 1981 Feb; (2):77-8. PubMed ID: 7222619
    [No Abstract]   [Full Text] [Related]  

  • 20. The influence of para-aminosalicylic acid on isonicotinic acid hydrazide blood levels after oral and intravenous administration.
    Kreukniet J; Blom van Assendelft PM; Mouton RP; Tasman A; Bangma PJ
    Scand J Respir Dis; 1966; 47(4):236-43. PubMed ID: 5182291
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.